A1CNow+ Multi-Test HbA1c System consists of (1) a semi-disposable plastic-encased device (the monitor), (2) a plastic cartridge enclosing dry reagent strips, and (3) a sample dilution kit for: collecting the blood sample, mixing the sample with the required pre-treatment solution, and delivering the sample to the cartridge.
Published October 30, 2024 · Recall initiated: September 18, 2024
Summary
FDA records medical device Class II recall Z-0223-2025, published October 30, 2024 and initiated September 18, 2024. Recalling firm: Polymer Technology Systems, Inc. dba PTS Diagnostics, Inc.; Status: Completed; Reported quantity: 2,452 units; Lot: UDI-DI: 00381933021011 Lot Numbers: 9331803, 2323019. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The reason for this recall is PTS Diagnostics, Inc. received complaints of non-matching cartridge and analyzer codes within the product test system box. Use of cartridges and analyzers with non-matching codes may result in inaccurate test results as components within each lot number are meant to be used together, and not mixed between lots. Therefore, the test results may possibly lead to Hemoglobin A1C positive or negative bias results. While the product is for monitoring only, over recovery with a higher than accurate value can be an indication for increased therapy; such as physical activity, weight reduction, meal management, pharmaceutical therapy.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Polymer Technology Systems, Inc. dba PTS Diagnostics, Inc.
- Distributor
- Worldwide distribution - US Nationwide and the countries of Japan, South Africa.
- Lot
- UDI-DI: 00381933021011 Lot Numbers: 9331803, 2323019
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAAD-TECH Spencer Probe Depth Electrode, REF SD08R-AP58X-000 8-Contact 1.12mm (A style) Depth ElectrodeOctober 30, 2024
- FDAQuantum Perfusion Systems for CPB, Roller Pumps use peristaltic action to propel blood through the venous andOctober 30, 2024
- FDAAD-TECH Spencer Probe Depth Electrode, REF SD06R-AP58X-000 6-Contact 1.12mm (A style) Depth ElectrodeOctober 30, 2024
- FDAEZDilate Wire Guided Balloon- Indicated for use in adult and adolescent (> 12 years) populations toOctober 30, 2024
- FDAAD-TECH Spencer Probe Depth Electrode, REF SD04R-AP58X-000 4-Contact 1.12mm (A style) Depth ElectrodeOctober 30, 2024
- FDABoston Scientific myLUX Patient Application for an Apple Mobile device, Model Number 2939, Version 2.0.101,October 30, 2024
Questions about this recall
Was A1CNow+ Multi-Test HbA1c System consists of (1) a semi-disposable plastic-encased device (the monitor), (2) a plastic cartridge enclosing dry reagent strips, and (3) a sample dilution kit for: collecting the blood sample, mixing the sample with the required pre-treatment solution, and delivering the sample to the cartridge. recalled?
Yes. FDA published recall Z-0223-2025 on October 30, 2024. Reported hazard: The reason for this recall is PTS Diagnostics, Inc. received complaints of non-matching cartridge and analyzer codes within the product test system box. Use of cartridges and analyzers with non-matching codes may result in inaccurate test results as components within each lot number are meant to be used together, and not mixed between lots. Therefore, the test results may possibly lead to Hemoglobin A1C positive or negative bias results. While the product is for monitoring only, over recovery with a higher than accurate value can be an indication for increased therapy; such as physical activity, weight reduction, meal management, pharmaceutical therapy.
What should I do if I have this product?
Voluntary: Firm initiated · Letter